Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2655${count})

  • Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023
    Validation of KLK6 as a New Therapeutic Target for Parkinson’s Disease

    Study Rationale: Alpha-synuclein is the main protein that aggregates and forms Lewy bodies, the hallmark histological characteristics of Parkinson disease (PD). Multiple experimental studies suggest...

  • Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2023
    Implementation and Validation of Lysosome-specific Tests of GCase Activity in Cell Lines and Human Peripheral Blood

    Study Rationale: Glucocerebrosidase (GCase) is an enzyme that is linked to Parkinson’s disease (PD) and is a high value target for disease-modifying treatments. Developing robust methods for...

  • Novel PET Tracer Development Program, 2023
    Monitoring Glucocerebrosidase Engagement in Parkinson’s Disease

    Study Rationale: Glucocerebrosidase is an enzyme that is essential for maintaining healthy lipid metabolism throughout the human body. In Parkinson’s disease (PD), the efficiency of this protein is...

  • Research Grant, 2023
    Developing Wiring Diagrams of the Brain-Body Connection

    Study Rationale: Individuals with Parkinson’s disease (PD) can show a variety of symptoms, including: resting tremors, alterations in directed hand movements, and treatment-induced dyskinesias; loss...

  • Data-Driven Subtyping and Stratification Program, 2023
    Identifying Proteomic Biomarkers for Monitoring the Progression of Parkinson’s Pathophysiology

    Study Rationale: Parkinson’s disease (PD) is often diagnosed at a stage where the disease has progressed significantly, restricting treatment options and limiting the opportunity to understand how the...

  • Circuits & Cellular Targets for PD’s Symptoms, 2023
    Pathophysiology of Neural Circuits Underlying Pain in Prodromal to Advanced Parkinson’s Disease

    Study Rationale: Many people with Parkinson’s disease (PD) suffer from pain that is not managed well by existing therapies. We believe the ineffectiveness of these treatment strategies may be due to a...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.